Product Images Sajazir

This appears to be a description of a prefilled syringe that includes a plunger and a capped needle, along with an alcohol wipe. Additional information is not available.*

SAJAZIR is a medication that may be administered via injection. The injection contains 30 mg of medication per 3 mL of fluid. The name of the medication appears to be "catibant," although further information is not available.*

SAJAZIR is a medication administered by subcutaneous injection containing 30 mg/3 mL of icatibant. It comes in a single-use prefilled syringe and is only intended for subcutaneous use. The drug is manufactured by Clpla Ltd. in India at M/s. Gland Pharma Limited, and is distributed by Cycle Pharmaceuticals Ltd. in Cambridge, UK. This information is for prescription use only (Rx Only), and contains an NDC number, a code, and a revision number.*

This is a description of a prescription medicine with the trade name SAJAZIR (icatibant) injection manufactured by Cipla Ltd. in India and M/s. Gland Pharma Ltd. in India. It is available in a 3 mL prefilled syringe and is intended for subcutaneous use only. The NDC number for this medicine is 70709-013-03, and it contains 30 mg/3 mL of the active ingredient. The medicine is made for Cycle Pharmaceuticals Ltd. in the UK.*

SAJAZIR is a prescription drug administered via subcutaneous injection. It is available as a single-dose, single-use, prefilled syringe that contains 30 mg/3 mL (10 mg/mL) of icatibant. The carton includes one syringe and one 25 G hypodermic needle. The syringe comes with a protective cap and should be stored between 2°C - 25°C (36°F - 77°F) and not frozen. SAJAZIR is manufactured by Cipla Ltd., India, and distributed by Cycle Pharmaceuticals Ltd, UK. The drug information, dosage, and administration are provided in the package insert.*

This is a product description for SAJAZIR (icatibant) injection, a prescription medication contained in a single-use, single-dose, prefilled syringe for subcutaneous use only. Each syringe contains 30 mg of icatibant in 3 mL and is closed with a protective cap. The inactive ingredients include sodium chloride, glacial acetic acid, sodium hydroxide, and water for injection. The carton also comes with one 26 gauge hypodermic needle and a package insert for full prescribing information, dosage and administration, along with full injection instructions for patients. It is manufactured by Cipla Ltd. in India and is sold and distributed by Cycle Pharmaceuticals Ltd. in Cambridge, UK. The recommended storage is between 2°C - 25°C (36°F - 77°F), without freezing. Batch overprinting occurs in an unvarnished area.*

This is a description of a medication contained in a prefilled syringe. The medication is Icatibant injection. It comes in a package with three cartons, each containing one single-dose, single-use pre-filled syringe with 25 G hypodermic needles. The prescribing information and patient injection instructions are printed on the package. The syringe contains 30 mg/3 mL of the medication, which is a subcutaneous injection. The medication is for prescription use only and should not be frozen. It is manufactured by Cipla Ltd. in India and by Gland Pharma Limited in India. The product seems to be produced for Cycle Pharmaceuticals Ltd. in Cambridge, UK.*